Molly Henderson Biography and Net Worth

Molly Henderson is the CFO of Phathom Pharmaceuticals.

What is Molly Henderson's net worth?: The estimated net worth of Molly Henderson is at least $1.32 million as of April 7th, 2025. Henderson owns 89,868 shares of Phathom Pharmaceuticals stock worth more than $1,321,060 as of December 4th. This net worth evaluation does not reflect any other assets that Henderson may own. Additionally, Henderson receives an annual salary of $777,760.00 as CFO at Phathom Pharmaceuticals. Learn More about Molly Henderson's net worth.
How old is Molly Henderson?: Henderson is currently 53 years old. There are 4 older executives and no younger executives at Phathom Pharmaceuticals. The oldest executive at Phathom Pharmaceuticals is Dr. Azmi Nabulsi M.D., M.P.H., Co-Founder & COO, who is 64 years old. Learn More on Molly Henderson's age.
What is Molly Henderson's salary?: As the CFO of Phathom Pharmaceuticals, Inc., Henderson earns $777,760.00 per year. There are 2 executives that earn more than Henderson. The highest earning executive at Phathom Pharmaceuticals is Ms. Terrie J. Curran, President, CEO & Director, who commands a salary of $1,220,000.00 per year. Learn More on Molly Henderson's salary.
How do I contact Molly Henderson?: The corporate mailing address for Henderson and other Phathom Pharmaceuticals executives is 100 CAMPUS DRIVE SUITE 102, FLORHAM PARK NJ, 07932. Phathom Pharmaceuticals can also be reached via phone at 877-742-8466 and via email at [email protected]. Learn More on Molly Henderson's contact information.
Has Molly Henderson been buying or selling shares of Phathom Pharmaceuticals?: Molly Henderson has not been actively trading shares of Phathom Pharmaceuticals in the last ninety days. Most recently, Molly Henderson sold 3,678 shares of the business's stock in a transaction on Monday, April 7th. The shares were sold at an average price of $4.55, for a transaction totalling $16,734.90. Following the completion of the sale, the chief financial officer now directly owns 89,868 shares of the company's stock, valued at $408,899.40. Learn More on Molly Henderson's trading history.
Who are Phathom Pharmaceuticals' active insiders?: Phathom Pharmaceuticals' insider roster includes Terrie Curran (Insider), Molly Henderson (CFO), Frank Karbe (Director), Azmi Nabulsi (COO), Asit Parikh (Director), David Socks (Director), and James Topper (Director). Learn More on Phathom Pharmaceuticals' active insiders.
Are insiders buying or selling shares of Phathom Pharmaceuticals?: During the last year, Phathom Pharmaceuticals insiders bought shares 3 times. They purchased a total of 21,280 shares worth more than $126,715.80. During the last year, insiders at the sold shares 9 times. They sold a total of 42,342 shares worth more than $284,083.77. The most recent insider tranaction occured on November, 3rd when insider Robert Charles Breedlove sold 524 shares worth more than $7,079.24. Insiders at Phathom Pharmaceuticals own 23.0% of the company. Learn More about insider trades at Phathom Pharmaceuticals.
Information on this page was last updated on 11/3/2025.

Molly Henderson Insider Trading History at Phathom Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/7/2025	Sell	3,678	$4.55	$16,734.90	89,868
1/21/2025	Sell	6,583	$6.59	$43,381.97	93,546
12/19/2024	Sell	1,291	$8.00	$10,328.00	98,156
7/15/2024	Sell	4,325	$11.72	$50,689.00	99,447
4/8/2024	Sell	3,435	$11.10	$38,128.50	95,263
1/19/2024	Sell	6,307	$7.75	$48,879.25	98,698
11/1/2023	Sell	12,492	$8.88	$110,928.96	105,188
6/2/2023	Sell	1,960	$11.41	$22,363.60	68,506
5/22/2023	Sell	2,110	$12.87	$27,155.70	70,466
4/6/2023	Sell	3,439	$7.27	$25,001.53	72,576
3/1/2023	Sell	2,032	$8.53	$17,332.96	76,015

Molly Henderson Buying and Selling Activity at Phathom Pharmaceuticals

Phathom Pharmaceuticals Company Overview

Phathom Pharmaceuticals, Inc., biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada for an investigational potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.

Today's Range

Now: $14.70

$14.27

$14.91

50 Day Range

MA: $13.53

$10.84

$15.60

2 Week Range

Now: $14.70

$2.21

$16.26

Volume

529,916 shs

Average Volume

812,243 shs

Market Capitalization

$1.05 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.43

Molly Henderson Biography and Net Worth

What is Molly Henderson's net worth?

How old is Molly Henderson?

What is Molly Henderson's salary?

How do I contact Molly Henderson?

Has Molly Henderson been buying or selling shares of Phathom Pharmaceuticals?

Who are Phathom Pharmaceuticals' active insiders?

Are insiders buying or selling shares of Phathom Pharmaceuticals?